(Q44796944)

English

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

scientific article published on 11 March 2004

Statements

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. (English)
0 references
Lorenz Trümper
Marita Kloess
Rudolf Schmits
Alfred C Feller
Christian Rübe
Christian Rudolph
Marcel Reiser
Dieter K Hossfeld
Hartmut Eimermacher
Dirk Hasenclever
Norbert Schmitz
Markus Loeffler
German High-Grade Non-Hodgkin's Lymphoma Study Group
11 March 2004
634-641

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit